Catalyst Wire Dossier Catalyst Wire Dossier

AR-102

· Aerie Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-102, covering 2014-05-08 to 2014-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Ocular Hypotensive Efficacy of AR-102 [Phase 2]

See pricing